Traws Pharma's total assets for Q2 2026 were $8.16M, a decrease of -23.18% from the previous quarter. TRAW total liabilities were $13.47M for the fiscal quarter, a 19.75% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.